Tecnetium (99m Tc) fanolesomab

N/A

Report date: 2025/09/08 11:00:31

Base Information

Drug NameTecnetium (99m Tc) fanolesomab
Drug Alias NameTechnetium Tc 99m Fanolesomab锝[99mTc]法索单抗Anti-CD15 IgM monoclonal antobody Tc 99mTechnetium 99m-labeled mouse anti-CD-15 IgM monoclonal antibodyFanolesomab-Tc 99m +[15] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsDiagnostic agent (In vivo) > Radionuclide Imaging agent +[6] 
Mechanisms of ActionAnti-CD15Radionuclide imaging enhancersSingle-photon emission-computed tomography enhancers
Targets3-fucosyl-N-acetyl-lactosamine
Therapy Area/IndicationsAppendicitis
Global Approved IndicationsAppendicitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2004/07/02
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPalatin Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPalatin Technologies Inc
Active IndicationsN/A
Inactive IndicationsAppendicitis

Other Information

ATC CodeL01XC
Related LinksWikipediaKEGG